World Journal of Endocrine Surgery

Register      Login

VOLUME 13 , ISSUE 1 ( January-April, 2021 ) > List of Articles

CASE REPORT

Parathyroid Adenoma Presenting as Acute Pancreatitis

Shaoni D Sanyal, Safika Zaman, Ajitesh Roy, Ranjan Raychowdhury

Keywords : Gallstones, Hypercalcemia, Parathyroid adenoma, Parathyroid neoplasms, Primary hyperparathyroidism

Citation Information : Sanyal SD, Zaman S, Roy A, Raychowdhury R. Parathyroid Adenoma Presenting as Acute Pancreatitis. World J Endoc Surg 2021; 13 (1):32-34.

DOI: 10.5005/jp-journals-10002-1318

License: CC BY-NC 4.0

Published Online: 20-11-2021

Copyright Statement:  Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Aim: To discuss an unusual presentation of parathyroid adenoma with management. Background: Primary hyperparathyroidism (PHPT) is characterized by hypercalcemia with elevated levels of parathyroid hormone (PTH). Parathyroid adenoma is the underlying cause in 85% of patients with PHPT. Case description: A 49-year-old woman presented with acute abdominal pain and was diagnosed to have acute pancreatitis. Routine investigations revealed hypercalcemia (serum calcium > 14 mg/dL) and elevated PTH (1,440 pg/mL). Initial ultrasound imaging of the neck showed an ill-defined hypoechoic space-occupying lesion with a cystic component in the lower pole of the right lobe of the thyroid gland. This was followed by a Sestamibi scan and SPECT CT. The patient underwent surgery after proper preoperative preparation. The level of PTH was reduced to 293 pg/mL on the first postoperative day. Serum calcium measured remained within normal limits. Conclusion: Pancreatitis is a rare presentation of parathyroid adenoma, but the diagnosis must be kept in mind while treating patients. Clinical significance: Patients with recurrent unexplainable pancreatitis should be worked up for parathyroid adenoma.


PDF Share
  1. Fraser WD. Hyperparathyroidism. Lancet 2009;374(9684):145–158. DOI: 10.1016/S0140-6736(09)60507-9.
  2. Adami S, Marcocci C, Gatti D. Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res 2002;17:N18–N23.
  3. Insogna KL. Primary hyperparathyroidism. N Eng J Med 2018;379(11):1050–1059. DOI: 10.1056/NEJMcp1714213.
  4. Bhadada SK, Arya AK, Mukhopadhyay S, et al. Primary hyperparathyroidism: insights from the Indian PHPT registry. J Bone Min Metabol 2018;36(2):238–245. DOI: 10.1007/s00774-017-0833-8.
  5. Aslam M, Talukdar R, Jagtap N, et al. Clinical profile and outcome of parathyroid adenoma-associated pancreatitis. Saudi J Med Med Sci 2018;6(2):95. DOI: 10.4103/sjmms.sjmms_80_17.
  6. Bess MA, Edis AJ, van Heerden JA. Hyperparathyroidism and pancreatitis: chance or a causal association. JAMA 1980;243(3):246–247. DOI: 10.1001/jama.1980.03300290028015.
  7. Kearns AE, Thompson GB. Medical and surgical management of hyperparathyroidism. In Mayo Clinic proceedings, vol. 77, No. 1. Elsevier; 2002. pp. 87–91.
  8. Felderbauer P, Karakas E, Fendrich V, et al. Pancreatitis risk in primary hyperparathyroidism: relation to mutations in the: SPINK1: trypsin inhibitor (N34S) and the cystic fibrosis gene. Am J Gastroenterol 2008;103(2):368–374. DOI: 10.1111/j.1572-0241.2007.01695.x.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.